Breaking News
0

Pot of Gold: Is It High Time To Invest In Cannabis?

By Leverate Technological Trading Ltd (Amram Margalit)Stock MarketsJun 12, 2018 08:59AM ET
www.investing.com/analysis/pot-of-gold--is-it-high-time-to-invest-in-cannabis-200324169
Pot of Gold: Is It High Time To Invest In Cannabis?
By Leverate Technological Trading Ltd (Amram Margalit)   |  Jun 12, 2018 08:59AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Legalization of cannabis has been at the forefront of the news as both a social and medical issue for the past few years. The issues are complex, and many countries have held serious public debate about whether and how to legalize marijuana and cannabis. Driven by medical research, countries are relaxing their stands and the market has responded with a significant uptick in cannabis-related growth and research. Companies that specialize in growing marijuana, companies that modify cannabis to maximize health benefits, medical marijuana suppliers and the like, have all grown with the increased opportunities afforded, as legalization and medicalization increase demand.

A snapshot of the US market gives an intriguing picture of the state of cannabis. To date, there are nine states, as well as the District of Columbia, that have made recreational marijuana use legal. For its use as a medicine, it is a legal substance in 29 states. However, at a federal level, it remains illegal. The situation where it can be legal at the state level but not at the federal level was made possible by the Obama administration's decision to grant the states autonomy over marijuana legalization. However, this situation may not continue for long. There are rumblings that current Attorney General Jeff Sessions will rescind the “non-interference” rule, and impose stronger restrictions on its use.

From an investment perspective, it is an interesting time in the history of cannabis. As the US shows, there has already been a move toward legislation for recreational use, opening up markets for growers and distributors. This market has reached a certain stage of maturity, but increased worldwide legalization will allow this to increase substantially, although there is no assurance that this will occur. Should legalization continue, it is possible that the growth and distribution market should grow substantially, likely mimicking the pathway shown by other items that share similarities - Coffee and Nicotine. Despite its growth being dependent on its continued legalization, current activities, like the recent drop in the Canadian Cannabis LP Index, shows that it may not all be smooth sailing. In Canada, despite price increase of 83% since last October, the index has dropped nearly 40% from its peak in January. This is due to a variety of factors, the primary one is that the expected legislation timeframe was pushed from July to September and a political bloodbath occurred during parliamentary deliberations on the bill.

These issues give a snapshot of the current state of the industry, providing an indication that investment thinking should have a longer-term focus. Canada’s challenges have also been impacted by new players coming into the market, making it difficult to assess which will be around for the long haul.

This is also true in the pharmaceutical space. However, with the high cost of R&D, it appears that the winners in this space are likely to be those companies that have added a cannabis division or product to their existing pipeline, rather than a cannabis only company. Certainly the early reports indicate that companies like AbbVie (NYSE:ABBV) and Insys (NASDAQ:INSY), established pharmaceutical companies with the funding and expertise to bring a drug through the long haul to market, have seen an uptick from their cannabis investments. Pharmaceutical cannabis will create an interest and funding for smaller cannabis dedicated research companies, but their ultimate success will be an exit to big pharma after clinical phase II or III. Finding those companies with the most promising commercial cannabis product will increasingly become equivalent to finding a needle in a haystack, as the interest cannabis has drawn will bring increasingly more research companies to the funding that it will offer. Pharmaceutical Cannabis is very much at the early stage of its market cycle. Investors need to recognize the long challenging road of pharmaceuticals approval and recognize the risk in early phase investment even for the most promising product.

All things considered, the cannabis market is still in its infancy, making it a great time to invest before the market takes off. However, newcomers must be cautious in choosing their stocks, diversify, and keep track of legalization news worldwide.

Pot of Gold: Is It High Time To Invest In Cannabis?
 

Related Articles

Pot of Gold: Is It High Time To Invest In Cannabis?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email